|
US6777217B1
(en)
|
1996-03-26 |
2004-08-17 |
President And Fellows Of Harvard College |
Histone deacetylases, and uses related thereto
|
|
US20030129724A1
(en)
|
2000-03-03 |
2003-07-10 |
Grozinger Christina M. |
Class II human histone deacetylases, and uses related thereto
|
|
EP1539744A4
(en)
*
|
2002-07-11 |
2007-06-06 |
Vicuron Pharm Inc |
N-HYDROXYAMIDE DERIVATIVES WITH ANTIBACTERIAL EFFECT
|
|
KR101076018B1
(ko)
*
|
2003-01-08 |
2011-10-21 |
유니버시티 오브 워싱톤 |
항균제
|
|
CA2532965C
(en)
|
2003-07-22 |
2013-05-14 |
Astex Therapeutics Limited |
3, 4-disubstituted 1h-pyrazole compounds and their use as cyclin dependent kinases (cdk) and glycogen synthase kinase-3 (gsk-3) modulators
|
|
MXPA06003951A
(es)
*
|
2003-10-07 |
2006-06-27 |
Renovis Inc |
Derivados de amida como ligandos del canal de ion y composiciones farmaceuticas y sus metodos de uso.
|
|
US7687435B2
(en)
*
|
2003-12-19 |
2010-03-30 |
Basf Aktiengesellschaft |
Benzoyl-substituted phenylalanineamides
|
|
US7468428B2
(en)
|
2004-03-17 |
2008-12-23 |
App Pharmaceuticals, Llc |
Lyophilized azithromycin formulation
|
|
US7638513B2
(en)
|
2004-06-02 |
2009-12-29 |
Schering Corporation |
Compounds for the treatment of inflammatory disorders
|
|
WO2006022442A1
(ja)
*
|
2004-08-24 |
2006-03-02 |
Santen Pharmaceutical Co., Ltd. |
ジヒドロオロテートデヒドロゲナーゼ阻害活性を有する新規複素環アミド誘導体
|
|
US7776869B2
(en)
|
2004-10-18 |
2010-08-17 |
Amgen Inc. |
Heteroaryl-substituted alkyne compounds and method of use
|
|
US8404718B2
(en)
|
2005-01-21 |
2013-03-26 |
Astex Therapeutics Limited |
Combinations of pyrazole kinase inhibitors
|
|
US20090088433A1
(en)
|
2005-01-26 |
2009-04-02 |
Bertrand Leblond |
Methods of using as analgesics 1-benzyl-1-hydroxy-2,3-diamino-propyl amines, 3-benzyl-3-hydroxy-2-amino-propionic acid amides and related compounds
|
|
US7576099B2
(en)
|
2005-02-28 |
2009-08-18 |
Renovis, Inc. |
Amide derivatives as ion-channel ligands and pharmaceutical compositions and methods of using the same
|
|
EA200701835A1
(ru)
*
|
2005-02-28 |
2008-02-28 |
Реновис, Инк. |
Амидные производные в качестве лигандов ионных каналов, их фармацевтические композиции и способы их применения
|
|
US8999289B2
(en)
|
2005-03-22 |
2015-04-07 |
President And Fellows Of Harvard College |
Treatment of protein degradation disorders
|
|
KR20080031379A
(ko)
*
|
2005-07-11 |
2008-04-08 |
와이어쓰 |
글루타메이트 아그레카나제 저해제
|
|
JP4961773B2
(ja)
*
|
2005-07-29 |
2012-06-27 |
住友ベークライト株式会社 |
芳香族カルボン酸及びその酸ハロゲン化物
|
|
JP2009520695A
(ja)
*
|
2005-12-15 |
2009-05-28 |
ヴィキュロン ファーマシューティカルズ インコーポレイテッド |
抗菌活性を有するｎ−ヒドロキシアミド誘導体
|
|
US8222423B2
(en)
|
2006-02-14 |
2012-07-17 |
Dana-Farber Cancer Institute, Inc. |
Bifunctional histone deacetylase inhibitors
|
|
US8304451B2
(en)
|
2006-05-03 |
2012-11-06 |
President And Fellows Of Harvard College |
Histone deacetylase and tubulin deacetylase inhibitors
|
|
CN101460470B
(zh)
|
2006-05-30 |
2011-05-18 |
阿斯利康(瑞典)有限公司 |
作为dgat1抑制剂的1,3,4-二唑衍生物
|
|
DE102006033321A1
(de)
*
|
2006-07-17 |
2008-01-24 |
Westfälische Wilhelms-Universität Münster |
Medizinische Verwendung von N-Phenylpropenoyl-Aminosäurederivaten und verwandten Verbindungen
|
|
EP2049124A4
(en)
|
2006-07-20 |
2010-02-10 |
Merck & Co Inc |
PHOSPHOR DERIVATIVES AS HISTONDEACETYLASE HEMMER
|
|
AU2007276763B2
(en)
*
|
2006-07-24 |
2011-03-17 |
University Of Maryland, Baltimore |
Heme oxygenase inhibitors and methods of therapeutic use
|
|
TW200821276A
(en)
*
|
2006-08-18 |
2008-05-16 |
Leo Pharma As |
Substituted acetylenic compounds useful for the treatment of diseases
|
|
WO2008027466A1
(en)
|
2006-08-31 |
2008-03-06 |
Schering Corporation |
Hydantoin derivatives useful as antibacterial agents
|
|
WO2008048589A2
(en)
*
|
2006-10-13 |
2008-04-24 |
Xtl Biopharmaceuticals Ltd |
Compounds and methods for treatment of hcv
|
|
WO2008053131A1
(en)
|
2006-10-30 |
2008-05-08 |
Chroma Therapeutics Ltd. |
Hydroxamates as inhibitors of histone deacetylase
|
|
US8563573B2
(en)
|
2007-11-02 |
2013-10-22 |
Vertex Pharmaceuticals Incorporated |
Azaindole derivatives as CFTR modulators
|
|
JP5227304B2
(ja)
*
|
2007-02-28 |
2013-07-03 |
大正製薬株式会社 |
新規なヒドロキサム酸誘導体
|
|
JP2010520875A
(ja)
|
2007-03-09 |
2010-06-17 |
レノビス， インコーポレイテッド |
Ｐ２ｘ７調節因子としてのビシクロヘテロアリール化合物およびその使用
|
|
TWI519508B
(zh)
*
|
2007-06-12 |
2016-02-01 |
Achaogen Inc |
抗菌劑
|
|
CN101417937B
(zh)
*
|
2007-10-23 |
2013-05-29 |
中山大学 |
β-醛酮类抗菌化合物及其应用
|
|
JP2011517313A
(ja)
|
2007-12-11 |
2011-06-02 |
ビアメト ファーマシューティカルズ，インク． |
金属結合部分を標的化部分と組み合わせて使用する金属酵素阻害剤
|
|
NZ586104A
(en)
|
2007-12-20 |
2012-02-24 |
Astrazeneca Ab |
Carbamoyl compounds as dgat1 inhibitors 190
|
|
US20110212078A1
(en)
|
2008-06-25 |
2011-09-01 |
Reddy Panduranga Adulla P |
Synthesis and use of heterocyclic antibacterial agents
|
|
AU2009274549B2
(en)
|
2008-07-23 |
2014-05-01 |
Dana-Farber Cancer Institute, Inc. |
Deacetylase inhibitors and uses thereof
|
|
EP2326619B1
(en)
|
2008-08-01 |
2019-02-27 |
Bioxiness Pharmaceuticals, Inc. |
Methionine analogs and methods of using same
|
|
WO2010017060A1
(en)
*
|
2008-08-04 |
2010-02-11 |
Schering Corporation |
Urea derivatives as antibacterial agents
|
|
US8273900B2
(en)
|
2008-08-07 |
2012-09-25 |
Novartis Ag |
Organic compounds
|
|
US8372885B2
(en)
*
|
2008-09-17 |
2013-02-12 |
Novartis Ag |
Organic compounds and their uses
|
|
JP5524215B2
(ja)
*
|
2008-09-19 |
2014-06-18 |
ファイザー・インク |
抗菌剤として有用なヒドロキサム酸誘導体
|
|
EP2177502A1
(en)
*
|
2008-10-17 |
2010-04-21 |
Oryzon Genomics, S.A. |
Compounds and their use
|
|
WO2010043721A1
(en)
|
2008-10-17 |
2010-04-22 |
Oryzon Genomics, S.A. |
Oxidase inhibitors and their use
|
|
US8993808B2
(en)
|
2009-01-21 |
2015-03-31 |
Oryzon Genomics, S.A. |
Phenylcyclopropylamine derivatives and their medical use
|
|
WO2011005355A1
(en)
*
|
2009-05-07 |
2011-01-13 |
Achaogen, Inc. |
Combinations comprising a lpxc inhibitor and an antibiotic for use in the treatment of infections caused by gram-negative bacteria
|
|
BRPI1008165B1
(pt)
*
|
2009-05-25 |
2020-02-27 |
Chiesi Farmaceutici S.P.A. |
Uma combinação terapêutica compreendendo um surfactante pulmonar e um esteróide
|
|
TW201103895A
(en)
|
2009-06-19 |
2011-02-01 |
Astrazeneca Ab |
Chemical compounds
|
|
WO2011019393A2
(en)
|
2009-08-11 |
2011-02-17 |
President And Fellows Of Harvard College |
Class- and isoform-specific hdac inhibitors and uses thereof
|
|
FR2950057B1
(fr)
|
2009-09-17 |
2011-08-26 |
Galderma Res & Dev |
Nouveaux composes benzene-carboxylamides, leur procede de synthese et leur utilisation en medecine ainsi qu'en cosmetique
|
|
FR2950056B1
(fr)
|
2009-09-17 |
2011-08-26 |
Galderma Res & Dev |
Nouveaux composes benzene-carboxylamides, leur procede de synthese et leur utilisation en medecine ainsi qu'en cosmetique
|
|
US8859555B2
(en)
|
2009-09-25 |
2014-10-14 |
Oryzon Genomics S.A. |
Lysine Specific Demethylase-1 inhibitors and their use
|
|
EP2486002B1
(en)
|
2009-10-09 |
2019-03-27 |
Oryzon Genomics, S.A. |
Substituted heteroaryl- and aryl- cyclopropylamine acetamides and their use
|
|
WO2011073845A1
(en)
|
2009-12-16 |
2011-06-23 |
Pfizer Inc. |
N-linked hydroxamic acid derivatives useful as antibacterial agents
|
|
WO2011106106A2
(en)
|
2010-02-24 |
2011-09-01 |
Oryzon Genomics, S.A. |
Lysine demethylase inhibitors for diseases and disorders associated with hepadnaviridae
|
|
WO2011106574A2
(en)
|
2010-02-24 |
2011-09-01 |
Oryzon Genomics, S.A. |
Inhibitors for antiviral use
|
|
US8802868B2
(en)
|
2010-03-25 |
2014-08-12 |
Vertex Pharmaceuticals Incorporated |
Solid forms of (R)-1(2,2-difluorobenzo[D][1,3]dioxo1-5-yl)-N-(1-(2,3-dihydroxypropyl-6-fluoro-2-(1-hydroxy-2-methylpropan2-yl)-1H-Indol-5-yl)-Cyclopropanecarboxamide
|
|
CA2796726C
(en)
|
2010-04-19 |
2021-02-16 |
Oryzon Genomics S.A. |
Lysine specific demethylase-1 inhibitors and their use
|
|
WO2011132712A1
(ja)
*
|
2010-04-20 |
2011-10-27 |
大正製薬株式会社 |
新規なヒドロキサム酸誘導体
|
|
ES2608474T3
(es)
|
2010-04-22 |
2017-04-11 |
Vertex Pharmaceuticals Incorporated |
Proceso de producción de compuestos indol cycloalkylcarboxamido
|
|
US9006449B2
(en)
|
2010-07-29 |
2015-04-14 |
Oryzon Genomics, S.A. |
Cyclopropylamine derivatives useful as LSD1 inhibitors
|
|
BR112013002164B1
(pt)
|
2010-07-29 |
2021-11-09 |
Oryzon Genomics S.A. |
Inibidores de desmetilase à base de arilciclopropilamina de lsd1, seus usos, e composição farmacêutica
|
|
WO2012031298A2
(en)
|
2010-09-03 |
2012-03-08 |
Duke University |
Ethynylbenzene derivatives
|
|
US9061966B2
(en)
|
2010-10-08 |
2015-06-23 |
Oryzon Genomics S.A. |
Cyclopropylamine inhibitors of oxidases
|
|
MX2013005200A
(es)
*
|
2010-11-10 |
2013-06-28 |
Achaogen Inc |
Derivados de acido hidroxamico y su so en el tratamiento de infecciones bacterianas.
|
|
WO2012072713A2
(en)
|
2010-11-30 |
2012-06-07 |
Oryzon Genomics, S.A. |
Lysine demethylase inhibitors for diseases and disorders associated with flaviviridae
|
|
PT2661433T
(pt)
|
2011-01-04 |
2017-10-24 |
Novartis Ag |
Compostos de indole ou seus análogos úteis para o tratamento da degeneração macular relacionada com a idade (amd)
|
|
EP2712315B1
(en)
|
2011-02-08 |
2021-11-24 |
Oryzon Genomics, S.A. |
Lysine demethylase inhibitors for myeloproliferative disorders
|
|
EP2678319B1
(en)
|
2011-02-22 |
2019-04-17 |
The General Hospital Corporation |
Antibiotic tolerance inhibitors
|
|
ES2626457T3
(es)
|
2011-03-07 |
2017-07-25 |
Pfizer Inc. |
Derivados de fluoro-piridinona útiles como agentes antibacterianos
|
|
CA2830866A1
(en)
|
2011-04-08 |
2012-10-11 |
Pfizer Inc. |
Imidazole, pyrazole, and triazole derivatives useful as antibacterial agents
|
|
ES2526687T3
(es)
|
2011-04-08 |
2015-01-14 |
Pfizer Inc. |
Derivados de isoxazol útiles como agentes antibacterianos
|
|
WO2013039947A1
(en)
|
2011-09-12 |
2013-03-21 |
Achaogen, Inc. |
Polymorphs of n-((s)-3-amino-1-(hydroxyamino)-3-methyl-1-oxobutan-2-yl)-4-(((1r,2r)-2-(hydroxymethyl)cyclopropyl)buta-1,3-diynyl)benzamide
|
|
JP6006609B2
(ja)
*
|
2011-10-19 |
2016-10-12 |
大正製薬株式会社 |
新規なヒドロキサム酸誘導体を含有する医薬
|
|
EP2768805B1
(en)
|
2011-10-20 |
2020-03-25 |
Oryzon Genomics, S.A. |
(hetero)aryl cyclopropylamine compounds as lsd1 inhibitors
|
|
JP6046154B2
(ja)
|
2011-10-20 |
2016-12-14 |
オリソン ヘノミクス エセ． アー． |
Ｌｓｄ１阻害剤としての（ヘテロ）アリールシクロプロピルアミン化合物
|
|
CA2864669A1
(en)
*
|
2012-02-16 |
2013-08-22 |
Rqx Pharmaceuticals, Inc. |
Linear peptide antibiotics
|
|
EP2847168A1
(en)
|
2012-05-10 |
2015-03-18 |
Achaogen, Inc. |
Antibacterial agents
|
|
ES2644700T3
(es)
|
2012-06-28 |
2017-11-30 |
Novartis Ag |
Derivados de pirrolidina y su uso como moduladores de la ruta del complemento
|
|
WO2014002058A2
(en)
|
2012-06-28 |
2014-01-03 |
Novartis Ag |
Complement pathway modulators and uses thereof
|
|
CN104379579B
(zh)
|
2012-06-28 |
2017-03-08 |
诺华股份有限公司 |
吡咯烷衍生物及其作为补体途径调节剂的用途
|
|
US9815819B2
(en)
|
2012-06-28 |
2017-11-14 |
Novartis Ag |
Complement pathway modulators and uses thereof
|
|
EP2867225B1
(en)
|
2012-06-28 |
2017-08-09 |
Novartis AG |
Pyrrolidine derivatives and their use as complement pathway modulators
|
|
CA2882724A1
(en)
|
2012-07-12 |
2014-01-16 |
Novartis Ag |
Complement pathway modulators and uses thereof
|
|
CN103012207B
(zh)
*
|
2012-12-29 |
2015-05-27 |
吉首大学 |
二芳基丙酰-n-甲基氧肟酸类尿素酶抑制剂及其合成和用途
|
|
WO2014165075A1
(en)
|
2013-03-12 |
2014-10-09 |
Achaogen, Inc. |
Antibacterial agents
|
|
DK2975022T3
(da)
|
2013-03-15 |
2019-07-15 |
Fujifilm Toyama Chemical Co Ltd |
Hidtil ukendt hydroxaminsyrederivat eller salt deraf
|
|
WO2014160649A1
(en)
*
|
2013-03-29 |
2014-10-02 |
Novartis Ag |
Hydroxamic acid derivatives as lpxc inhibitors for the treatment of bacterial infections
|
|
WO2015024021A2
(en)
|
2013-08-16 |
2015-02-19 |
Duke University |
Antibacterial compounds
|
|
US10647664B2
(en)
|
2013-08-16 |
2020-05-12 |
Duke University |
Substituted hydroxamic acid compounds
|
|
WO2015024016A2
(en)
*
|
2013-08-16 |
2015-02-19 |
Duke University |
2-piperidinyl substituted n,3-dihydroxybutanamides
|
|
GB201315335D0
(en)
|
2013-08-29 |
2013-10-09 |
Of Singapore |
Amino diacids containing peptide modifiers
|
|
US9539305B1
(en)
|
2014-03-14 |
2017-01-10 |
Fleurir Abx Llc |
Pristinamycin compositions, LpxC compositions, their improvements, and combinations thereof
|
|
ES2885181T3
(es)
|
2014-04-15 |
2021-12-13 |
Vertex Pharma |
Composiciones farmacéuticas para el tratamiento de enfermedades mediadas por el regulador de la conductancia transmembrana de fibrosis quística
|
|
EP3134401B1
(en)
|
2014-04-22 |
2018-06-13 |
Novartis AG |
Isoxazoline hydroxamic acid derivatives as lpxc inhibitors
|
|
JPWO2016039432A1
(ja)
|
2014-09-12 |
2017-06-22 |
富山化学工業株式会社 |
新規なヒドロキサム酸誘導体および抗菌性物質を組み合わせて使用する方法
|
|
BR112017004798A2
(pt)
|
2014-09-12 |
2017-12-12 |
Toyama Chemical Co Ltd |
composição farmacêutica que contém um derivado de ácido hidroxâmico ou um seu sal
|
|
CN104341476A
(zh)
*
|
2014-10-11 |
2015-02-11 |
吉首大学 |
利奈唑胺-肌苷型多靶点抗菌化合物及其制法和用途
|
|
CN104327140B
(zh)
*
|
2014-10-11 |
2016-06-15 |
吉首大学 |
噁唑烷酮-腺苷型多靶点抗菌化合物及其制法和用途
|
|
CN104341475A
(zh)
*
|
2014-10-11 |
2015-02-11 |
吉首大学 |
利奈唑胺-腺苷型多靶点抗菌化合物及其制法和用途
|
|
CN104231024B
(zh)
*
|
2014-10-11 |
2016-06-15 |
吉首大学 |
噁二唑-肌苷型化合物作为TyrRS抑制剂及其制法和用途
|
|
CN104262433B
(zh)
*
|
2014-10-11 |
2016-06-15 |
吉首大学 |
噁二唑-腺苷型化合物作为TyrRS抑制剂及其制法和用途
|
|
DK3233843T3
(da)
*
|
2014-12-16 |
2019-11-18 |
Novartis Ag |
Isoxazol-hydraxamsyreforbindelser som LPXC-hæmmere
|
|
CN105777464B
(zh)
*
|
2014-12-26 |
2020-09-29 |
中国科学院上海药物研究所 |
异羟肟酸衍生物及其制备方法和应用
|
|
CN107709314A
(zh)
|
2015-06-11 |
2018-02-16 |
巴斯利尔药物国际股份公司 |
外排泵抑制剂及其治疗性用途
|
|
WO2017042099A1
(en)
*
|
2015-09-09 |
2017-03-16 |
Basilea Pharmaceutica Ag |
Efflux-pump inhibitors and therapeutic uses thereof
|
|
EP3374350B1
(en)
|
2015-11-09 |
2022-01-05 |
Forge Therapeutics, Inc. |
Hydroxypyridinone and hydroxypyrimidinone based compounds for treating bacterial infections
|
|
WO2017083434A1
(en)
|
2015-11-09 |
2017-05-18 |
Forge Therapeutics, Inc. |
Pyrone based compounds for treating bacterial infections
|
|
EP3386950A1
(en)
*
|
2015-12-08 |
2018-10-17 |
GlaxoSmithKline Intellectual Property Development Limited |
Substituted benzazinones as antibacterial compounds
|
|
EP3426674A4
(en)
|
2016-03-09 |
2019-08-14 |
Blade Therapeutics, Inc. |
CYCLIC KETO AMID COMPOUNDS AS CALPAIN MODULATORS AND METHOD FOR THE PRODUCTION AND USE THEREOF
|
|
PL3445744T3
(pl)
*
|
2016-04-18 |
2022-02-07 |
Vivoryon Therapeutics Ag |
Nowe inhibitory mepryny alfa i beta
|
|
EP4286001A3
(en)
*
|
2016-04-25 |
2024-07-17 |
Duke University |
Benzoylglycine derivatives and methods of making and using same
|
|
JP6941630B2
(ja)
|
2016-06-14 |
2021-09-29 |
ノバルティス アーゲー |
抗菌剤としての（ｒ）−４（５−（シクロプロピルエチニル）イソオキサゾール−３−イル）−ｎ−ヒドロキシ−２−メチル−２−（メチルスルホニル）ブタンアミドの結晶形
|
|
EA201990070A1
(ru)
|
2016-06-21 |
2019-06-28 |
ОРИОН ОФТАЛМОЛОДЖИ ЭлЭлСи |
Производные алифатического пролинамида
|
|
PL3472149T3
(pl)
|
2016-06-21 |
2024-02-12 |
Orion Ophthalmology LLC |
Heterocykliczne pochodne prolinamidu
|
|
US10526315B2
(en)
|
2016-06-21 |
2020-01-07 |
Orion Ophthalmology LLC |
Carbocyclic prolinamide derivatives
|
|
AR108864A1
(es)
|
2016-06-23 |
2018-10-03 |
Achaogen Inc |
Agentes antibacterianos
|
|
AU2017292646A1
(en)
|
2016-07-05 |
2019-02-07 |
Blade Therapeutics, Inc. |
Calpain modulators and therapeutic uses thereof
|
|
WO2018064119A1
(en)
|
2016-09-28 |
2018-04-05 |
Blade Therapeutics, Inc. |
Calpain modulators and therapeutic uses thereof
|
|
BR112019012861A2
(pt)
*
|
2016-12-23 |
2019-12-10 |
Intervet Int Bv |
compostos para o tratamento de doença respiratória bovina ou suína
|
|
MX388647B
(es)
*
|
2016-12-23 |
2025-03-20 |
Intervet Int Bv |
Compuestos utiles para el tratamiento de una infeccion por mannheimia haemolytica o histophilus somni.
|
|
US11021471B2
(en)
|
2017-05-10 |
2021-06-01 |
Forge Therapeutics, Inc. |
Antibacterial compounds
|
|
WO2018213185A1
(en)
*
|
2017-05-17 |
2018-11-22 |
Drexel University |
Rela inhibitors for biofilm disruption
|
|
AU2018300150A1
(en)
|
2017-07-11 |
2020-01-30 |
Vertex Pharmaceuticals Incorporated |
Carboxamides as modulators of sodium channels
|
|
US11351126B2
(en)
|
2017-07-27 |
2022-06-07 |
BioMendics, LLC |
Substituted tolans for the modulation of microbial colonization
|
|
BR112020016270A2
(pt)
*
|
2018-02-10 |
2020-12-15 |
Kbp Biosciences Co., Ltd. |
Composto atuando como antibióticos
|
|
AU2019345150A1
(en)
|
2018-09-20 |
2021-05-13 |
Blacksmith Medicines, Inc. |
Antibacterial compounds
|
|
JP7189368B2
(ja)
|
2018-10-30 |
2022-12-13 |
ギリアード サイエンシーズ， インコーポレイテッド |
アルファ４ベータ７インテグリンの阻害のための化合物
|
|
FI3873884T3
(fi)
|
2018-10-30 |
2025-02-24 |
Gilead Sciences Inc |
3-(kinolin-8-yyli)-1,4-dihydropyrido[3,4-d]pyrimidiini-2,4-dionijohdannaisia alfa-4-beta-7-integriinin estäjinä tulehdussairauksien hoidossa
|
|
ES3013256T3
(en)
|
2018-10-30 |
2025-04-11 |
Gilead Sciences Inc |
Imidazo[1,2-a]pyridine derivatives as alpha4beta7 integrin inhibitors for the treatment of inflammatory diseases
|
|
EP3873605B1
(en)
|
2018-10-30 |
2024-10-23 |
Gilead Sciences, Inc. |
Compounds for inhibition of alpha4beta7 integrin
|
|
WO2020146682A1
(en)
|
2019-01-10 |
2020-07-16 |
Vertex Pharmaceuticals Incorporated |
Carboxamides as modulators of sodium channels
|
|
US12440481B2
(en)
|
2019-01-10 |
2025-10-14 |
Vertex Pharmaceuticals Incorporated |
Esters and carbamates as modulators of sodium channels
|
|
JP2022521600A
(ja)
*
|
2019-02-22 |
2022-04-11 |
シラ セラピューティック インコーポレイティッド |
吸入可能な治療剤
|
|
WO2021030438A1
(en)
|
2019-08-14 |
2021-02-18 |
Gilead Sciences, Inc. |
Compounds for inhibition of alpha 4 beta 7 integrin
|
|
CN110563611B
(zh)
|
2019-09-19 |
2021-02-02 |
中国医学科学院医药生物技术研究所 |
一种异羟肟酸类衍生物及其制备方法和应用
|
|
BR112022010924A2
(pt)
|
2019-12-06 |
2022-09-06 |
Vertex Pharma |
Tetra-hidrofuranos substituídos como moduladores de canais de sódio
|
|
CN111254091B
(zh)
*
|
2020-01-20 |
2022-04-19 |
浙江工业大学 |
一种嗜麦芽窄食单胞菌gyh及其在降解氯代烃类污染物中的应用
|
|
WO2021195260A1
(en)
|
2020-03-25 |
2021-09-30 |
Forge Therapeutics, Inc. |
Lpxc inhibitor and methods of making
|
|
PH12022553378A1
(en)
|
2020-06-10 |
2024-03-25 |
Univ Leuven Kath |
Anti-viral compounds for treating coronavirus, picornavirus, and norovirus infections
|
|
SMT202500481T1
(it)
|
2021-06-04 |
2026-01-12 |
Vertex Pharma |
N-(idrossialchil(etero)aril)tetraidrofuran carbossammidi come modulatori di canali del sodio
|
|
AU2022306289A1
(en)
|
2021-07-09 |
2024-01-18 |
Aligos Therapeutics, Inc. |
Anti-viral compounds
|
|
WO2023043816A1
(en)
|
2021-09-17 |
2023-03-23 |
Aligos Therapeutics, Inc. |
Anti-viral compounds for treating coronavirus, picornavirus, and norovirus infections
|
|
TW202322818A
(zh)
|
2021-09-28 |
2023-06-16 |
美商福吉醫療公司 |
Lpxc抑制劑及其用途
|
|
WO2023128033A1
(ko)
*
|
2021-12-31 |
2023-07-06 |
(주)앰틱스바이오 |
감염성 진균의 바이오필름 생성을 억제하는 신규한 항진균용 조성물
|
|
CN116730870B
(zh)
*
|
2023-08-08 |
2023-10-13 |
中国医学科学院医药生物技术研究所 |
异羟肟酸类化合物或其可药用盐、及其用途和制备方法
|
|
CN119350185A
(zh)
*
|
2024-10-08 |
2025-01-24 |
聊城大学 |
一种联苯羟肟类衍生物及其制备方法和用途
|